Ipsalazide is primarily used in the treatment of inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease. It works by reducing inflammation in the digestive tract, helping to alleviate symptoms like abdominal pain, diarrhea, and rectal bleeding. The compound is designed to target the affected areas directly, minimizing systemic side effects. It is often prescribed when other treatments have not been effective or are not suitable for the patient. Ipsalazide may also be used as a maintenance therapy to prevent flare-ups and maintain remission in chronic cases of IBD. Its application is tailored to individual patient needs, often in combination with other medications or dietary adjustments.